Log in to search using one of your social media accounts:

 

7 medtech stories we missed this week: Nov. 3, 2017
[Image from unsplash.com]From Hologic’s new product launch to CapsoVision gettting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Hologic launches new MyoSure device Hologic announced in a Nov. 1 press release that it has launched its MyoSure Manual Device in the U.S. The device is designed to help doctors resect and remove intrauterine tissue easily in an office setting if used with the MyoSure hysteroscope. 2. IntraFuse wins FDA clearance for FlexThread fibula pin IntraFuse has received FDA 510(k) clearance for its FlexThread Fibula Pin System, ...
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Endoscopic / Arthroscopic Oncology Orthopedics Pain Management Regulatory/Compliance Surgical Ultrasound Women's Health brhmedical CapsoVision Helomics Hologic Inc. IntraFuse MedTech Sensus Healthcare LLC Skyline Med Source Type: news

New insight into how excess belly fat may increase cancer risk
Conclusion This animal and laboratory study investigated the possible cellular relationship between excess body fat – specifically fat around the body organs – and cancer risk. It seems one key mechanism by which excess visceral fat could stimulate healthy cells to develop into cancerous ones could be through FGF2 levels. The researchers hope their study could pave the way for possible cancer prevention strategies by stopping FGF2 production in obese people with excess belly fat. They even go as far as suggesting that blocking FGF2 receptors could be one part of a treatment approach after a diagnosis of breas...
Source: NHS News Feed - September 1, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Pathway's power to boost, halt tumors may be promising cancer therapy target
(Penn State) A protein, called inositol-requiring enzyme 1 -- IRE1 -- may serve as a key driver in a series of molecular interactions that can both promote and, paradoxically, inhibit tumors in certain types of cancers, such as non-melanoma skin cancers, according to a team of molecular biologists. They add that this pathway's dual power may make it a tempting target for future research on the design of new types of anti-cancer therapeutics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 29, 2017 Category: Cancer & Oncology Source Type: news

Arsenic Levels Higher in Patients With Nonmelanoma Skin Cancers
Much higher levels of inorganic arsenic, trivalent, pentavalent arsenic, monomethylarsonic acid (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 21, 2017 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pathology, Journal, Source Type: news

Proposed: Trial of Vitamin Derivative to Prevent Melanoma Proposed: Trial of Vitamin Derivative to Prevent Melanoma
The vitamin B3 derivative nicotinamide was previously shown to reduce nonmelanoma skin cancers in a phase 3 trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Alcohol linked to an increased risk of skin cancer
Conclusion These findings should be interpreted with care before concluding that an alcoholic drink per day increases your risk of skin cancer. There are several important cautions: These are only observational studies. It wouldn't be possible to randomise people to different alcohol intake and follow them to look at cancer development. And with observational studies, many other health, sociodemographic and lifestyle factors may be influencing the link between alcohol intake and cancer development. The studies differed considerably in terms of the influencing factors they took account of, with some adjusting for various ...
Source: NHS News Feed - August 7, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Review: Positive Link for Alcohol, Nonmelanoma Skin Cancer
For every 10 - g increase in ethanol intake per day, positive correlation seen for BCC, cutaneous SCC (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 31, 2017 Category: Cancer & Oncology Tags: Dermatology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Journal, Source Type: news

Alcohol intake may increase risk of nonmelanoma skin cancers
(Wiley) In a recent analysis of published studies, higher alcohol intake was linked with an increased risk of both basal cell carcinoma and cutaneous squamous cell carcinoma, which are nonmelanoma skin cancers. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 31, 2017 Category: International Medicine & Public Health Source Type: news

Immunotherapy Safely Treats Advanced Squamous Cell Carcinoma
An anti –PD-1 monoclonal antibody is safe and effective for patients with unresectable, locally advanced, or metastatic cutaneous squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - June 23, 2017 Category: Cancer & Oncology Authors: Mark L. Fuerst Tags: News Skin Cancer (Nonmelanoma) Source Type: news

Episode #15: How easy is it to get addicted to opioids?
TPR PODCAST EPISODE #15: HOW EASY IS IT TO GET ADDICTED TO OPIOIDS?     As has been well reported in medical papers, government studies and popular media, rates of overdose deaths from opioids have been increasing steadily over the last several decades. A recent article in the New York Times reported that there were likely more than 59,000 drug overdose deaths in 2016, an estimated 19% increase over the number in 2015. The total for 2017 is likely to be even higher.   Many deaths have been associated with prescription opioid analgesics, or have occurred among patients who became addicted to prescription opio...
Source: The Poison Review - June 11, 2017 Category: Toxicology Authors: Leon Gussow The Poison Review Tags: Podcast Source Type: news

PERFI Feasible for In Vivo Imaging of Nonmelanoma Skin Cancer
Methylene blue infused into peritumoral space, and preferentially retained in tumor (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 2, 2017 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pathology, Journal, Source Type: news

First-ever global study finds massive health care inequity
A first-ever global study finds massive inequity of access to and quality of health care among and within countries, and concludes people are dying from causes with well-known treatments. For example, on a scale of 1 to 100 for health care access and quality, Norway and Australia each scored 90 overall, among the highest in the world. However, Norway scored 65 in its treatment for testicular cancer, and Australia scored 52 for treating non-melanoma skin cancer. (Source: World Pharma News)
Source: World Pharma News - May 18, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Skin cancer on the rise
New diagnoses for two types of skin cancer increased in recent years, according to a team of researchers. Their paper uses medical records from the Rochester Epidemiology Project to compare diagnoses of basal cell carcinoma and squamous cell carcinoma ? both nonmelanoma skin cancers ? between 2000 and 2010 to diagnoses in prior years. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 15, 2017 Category: Science Source Type: news

Are walnuts the key to fighting prostate cancer? Researchers think so
(Natural News) Next to non-melanoma skin cancer, prostate cancer is the most prevalent cancer among men in America, according to the latest statistics from the Centers for Disease Control and Prevention (CDC). In 2013, 176,450 new cases of prostate cancer were diagnosed, and about 27,681 American men died from this largely preventable disease. The prostate... (Source: NaturalNews.com)
Source: NaturalNews.com - March 14, 2017 Category: Consumer Health News Source Type: news

Novel, Immune Therapies Promising in Nonmelanoma Skin Cancers
Treatment of keratinocyte carcinomas such as basal cell carcinoma and cutaneous squamous cell carcinoma with PD-1 checkpoint inhibitors and targeted agents warrant further investigation, according to recently published studies. (Source: CancerNetwork)
Source: CancerNetwork - March 9, 2017 Category: Cancer & Oncology Authors: Ian Ingram Tags: News Skin Cancer (Nonmelanoma) Source Type: news

Mohs an Option in Older Patients with Non-Melanoma Skin Ca
(MedPage Today) -- Good 8-year survival outcomes seen in patients 85 and up (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 7, 2017 Category: Dermatology Source Type: news

Study defines global burden of skin disease
(University of Colorado Anschutz Medical Campus) A study published today in JAMA Dermatology combines the prevalence of skin diseases around the world with their likelihood of creating disability across the lifespan to define the following 10 most challenging conditions (arranged in order of decreasing 'disability-adjusted life years'): dermatitis, acne, hives, psoriasis, viral skin diseases, fungal skin diseases, scabies, melanoma, pyoderma, cellulitis, non-melanoma skin cancer, decubitus ulcer, and alopecia areata. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 1, 2017 Category: Cancer & Oncology Source Type: news

Nonmelanoma Skin Cancer: A Primer for Primary Care
Primary care physicians will see many patients with early signs of nonmelanoma skin cancers. Test your visual diagnostic skills in this series. (Source: ConsultantLive)
Source: ConsultantLive - February 6, 2017 Category: Internal Medicine Authors: Eve J. Lowenstein, MD, PhD Tags: Special Report Skin Diseases Source Type: news

Tattoos mark the spot for surgery, then disappear
Tattoos aren't just for body art. They can have medical applications, too. Doctors are using them on patients to mark an area for future treatment -- particularly for non-melanoma skin cancer such as basal cell carcinoma -- but the inks can cause problems. Now scientists have developed a better solution. In a new article, they report a new ink that glows only under certain light conditions and can disappear altogether after a period of time. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 21, 2016 Category: Science Source Type: news

Tattoos mark the spot -- for surgery -- then disappear
(American Chemical Society) Tattoos aren't just for body art. They can have medical applications, too. Doctors are using them on patients to mark an area for future treatment -- particularly for non-melanoma skin cancer such as basal cell carcinoma -- but the inks can cause problems. Now scientists have developed a better solution. In the journal ACS Nano, they report a new ink that glows only under certain light conditions and can disappear altogether after a period of time. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2016 Category: Global & Universal Source Type: news

More foreign holidays will mean more skin cancer, scientists predict
A 78% increase in non-melanoma skin cancer may see the cost to the NHS of treating the disease rise to £465m a year by 2025The number of Britons developing the two most common forms of skin cancer will increase as a direct result of people getting tans on foreign holidays and in salons, experts are warning.Related:Scientists closer to understanding why red hair genes increase skin cancer riskContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 8, 2016 Category: Science Authors: Denis Campbell Health policy editor Tags: Skin cancer Society Health Cancer research Medical research Science UK news NHS The sun Source Type: news

The Role of Life Expectancy in Skin Cancer Treatment Decisions The Role of Life Expectancy in Skin Cancer Treatment Decisions
Are patients with limited life expectancy more likely to receive less aggressive and invasive treatment for non-melanoma skin cancers?Journal of the American Geriatrics Society (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 30, 2016 Category: Surgery Tags: Hematology-Oncology Journal Article Source Type: news

15th Anniversary of 9/11: Mesothelioma Expected to Rise from Attack
Thoracic surgeon Dr. Raja Flores, like so many other patriotic Americans, rushed to help after the horrific 9/11 terrorist attack at the World Trade Center (WTC) in New York City. As the world prepares to commemorate the 15th anniversary of the 9/11 attacks, Flores’ work is far from done. While the memory of that fateful Sept. 11, 2001, is beginning to fade for many, the threat of a resulting and significant rise in mesothelioma cancer is looming large on the horizon. The alarming number of future mesothelioma cases will stem from the weeks-long rescue and cleanup efforts performed under the toxic cloud that containe...
Source: Asbestos and Mesothelioma News - September 8, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: 15th anniversary 9/11 9/11 15 year anniversary 9/11 attack at world trade center 9/11 mesothelioma cases 9/11 terrorist attack asbestos after 9/11 attack asbestos in 9/11 attack Source Type: news

Vitamin D Intake Associated With Basal Cell Carcinoma Risk
Oral vitamin D intake was associated with an increased risk for basal cell carcinoma, but not melanoma, according to two large cohort studies. (Source: CancerNetwork)
Source: CancerNetwork - September 4, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Melanoma News Skin Cancer (Nonmelanoma) Source Type: news

Featured Review: Sun protection to prevent basal cell carcinoma and cutaneous squamous cell carcinoma of the skin
One randomised trial has been done to date that compares different ways of using sunscreen and physical barrier methods to protect against common non-melanoma skin cancers. The quality of evidence to date is low but the review team urge caution in changing behaviour on the basis of the review findings.Keratinocyte cancer is a more common but less serious type of skin cancer than melanoma. It comprises basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). The main risk factor for keratinocyte cancer is exposure to ultraviolet radiation, which is a component of sunlight. The incidence of this type of cance...
Source: Cochrane News and Events - August 10, 2016 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

The Top 5 Nutrients For Healthy Skin
We all want that dewy, youthful glow to our skin and there's no better way to make that happen than to eat a healthy, balanced diet. Our skin's appearance is the first thing people notice and when our skin looks good, we feel good about ourselves. To obtain beautiful skin, it begins from the inside out. Our food choices make a huge difference and when we feed ourselves the nutrients to make this happen, our skin is a reflection of that. Some of our biggest beauty concerns have to do with appearance of aging skin - wrinkles, discoloration, adult acne, and sagging skin. There are many factors that can determine how well ...
Source: Healthy Living - The Huffington Post - August 2, 2016 Category: Consumer Health News Source Type: news

Sensus Healthcare, Inc. Names Anthony Petrelli to its Board of Directors
BOCA RATON, Fla., Aug. 2, 2016 -- (Healthcare Sales & Marketing Network) -- Sensus Healthcare, Inc. (SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial ra... Devices, Dermatology, Oncology, Personnel Sensus Healthcare, superficial radiation therapy, skin cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 2, 2016 Category: Pharmaceuticals Source Type: news

Not Enough Evidence to Balance Harms, Benefit of Visual Skin Cancer Exam
There is currently not enough evidence to assess the balance of benefits and harms of a visual skin examination by a clinician to screen for skin cancer in asymptomatic adults. (Source: CancerNetwork)
Source: CancerNetwork - July 29, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Melanoma News Skin Cancer (Nonmelanoma) Source Type: news

Does Smoking Make You Look Older
Research shows smokers more susceptible to non-melanoma skin cancers, wrinkles, skin aging, psoriasis, dental problems and hair loss (Source: Disabled World)
Source: Disabled World - July 20, 2016 Category: Disability Tags: Dermatology Source Type: news

15, 30, 50, 70... Which SPF Should I Use?
By GalTime.com Seems like you need a PhD in SPF these days to understand what's on the label of most sunscreens. And believe you me, you want to make sure you have the right sunscreen slathered on your body before you hit the beach! Non-melanoma skin cancer is now the most common type of cancer in America. More than 3.5 million cases are reported annually... and that's just the reported cases. Many patients are treated in the doctor's office and a good number of those aren't included in the count. That's why the Archives of Dermatology recently called non-melanoma skin cancer an "under-recognized epidemic" in t...
Source: Healthy Living - The Huffington Post - July 19, 2016 Category: Consumer Health News Source Type: news

Many skin cancer patients still too likely to sunburn
A recent study concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without previous history, probably because they are not using sun-protective methods the right way or in the right amounts. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 19, 2016 Category: Science Source Type: news

Many skin cancer patients still too likely to sunburn
(Johns Hopkins Medicine) A recent study by researchers at Johns Hopkins concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without previous history, probably because they are not using sun-protective methods the right way or in the right amounts. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 19, 2016 Category: Cancer & Oncology Source Type: news

'Secret ginger gene' may increase skin cancer risk for millions
Conclusion The study adds more weight to the importance of using sun protection to avoid skin cancer. We already know that people with red hair and freckles who burn easily are at increased risk of skin cancer. This study suggests other people may also have a higher risk, without knowing it. Taking sensible sun protection measures makes good sense for everyone. The findings are also useful for researchers, as they add to our understanding about how certain genetic traits affect the development of skin cancer. If DNA repair is reduced in people with some gene variants, sun damage may not be the only thing affecting th...
Source: NHS News Feed - July 13, 2016 Category: Consumer Health News Tags: Cancer Genetics/stem cells Source Type: news

Everything You Need To Know About Choosing The Best Sunscreen
Fourth of July weekend is upon us, and along with barbecue equipment, beach toys and sandals, don't forget to stock up on some sunscreen for the holiday. Sun damage is responsible for 90 percent of nonmelanoma skin cancers in the United States, itself the most common form of cancer in the country, according to the Skin Cancer Foundation. In fact, more than 3.3 million people are diagnosed with skin cancer in the U.S. each year. The Food and Drug Administration recommends that consumers look for three things in their sunscreen: a "sun protection factor" (SPF) of 15 or more, "broad spectrum" protec...
Source: Healthy Living - The Huffington Post - July 1, 2016 Category: Consumer Health News Source Type: news

Sensus Healthcare closes $11m IPO
Sensus Healthcare (NSDQ:SRTSU) said today it closed its initial public offering, raising $11 million through the sale of 2.3 million units at $5.50 each. The offering included a fully-exercised underwriters option of an additional 300,000 units at the IPO price, Sensus said. Each share consists of a unit of stock and a 3-year warrant with an exercise price of $6.75. The offering units are slated to split by July 25, with the stock shares trading on the NASDAQ exchange under the “SRTS” symbol and the warrants under the “SRTSW” symbol. Sensus makes low-energy photon X-ray systems for treating non...
Source: Mass Device - June 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Funding Roundup Initial Public Offering (IPO) Radiosurgery Sensus Healthcare LLC Source Type: news

Sensus Healthcare prices $11m IPO
Sensus Healthcare (NSDQ:SRTSU) priced an $11 million initial public offering yesterday, saying it plans to float 2 million shares at $5.50 apiece starting today. Boca Raton, Fla.-based Sensus said the offering, expected to close June 8, also includes a 300,000-unit over-allotment option for the IPO’s underwriters. Each share consists of a unit of stock and a 3-year warrant with an exercise price of $6.75. The offering units are slated to split by July 25, with the stock shares trading on the NASDAQ exchange under the “SRTS” symbol and the warrants under the “SRTSW” symbol. Sensus mak...
Source: Mass Device - June 3, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Radiosurgery Wall Street Beat Sensus Healthcare LLC Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 16, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Otsuka gets in on ReCor Medical’s Paradise renal denervation device ReCor Medical said it landed a strategic investment from Japanese conglomerate Otsuka Pharmaceutical that will bring to Asia its Paradise renal denervati...
Source: Mass Device - May 16, 2016 Category: Medical Equipment Authors: MassDevice Tags: Blog Plus 5 Source Type: news

Sensus Healthcare scales back planned IPO
Sensus Healthcare last week said it plans to scale back its planned initial public offering, after tabling the flotation earlier this year. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100 Vision photon X-ray low-energy superficial radiotherapy systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinomas. The company said March 9 that it planned to float more than 1.8 million shares at $10 to $12 apiece, working out to a low-end raise of $18.2 million and a high end of $21.8 million. Later that month, Sensus postponed the IPO. But in a May 13 regulatory fi...
Source: Mass Device - May 16, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Oncology Radiosurgery Sensus Healthcare LLC Source Type: news

Search is on for cases of aggressive, ruxolitinib-associated skin cancers
ORLANDO – The hematologic cancer drug ruxolitinib seems to be associated with cases of aggressive nonmelanoma skin cancer. After treating a very aggressive squamous cell carcinoma in a 55-year-old man treated with ruxolitinib for polycythemia vera, and hearing firsthand of three other similar... (Source: Skin and Allergy News)
Source: Skin and Allergy News - April 30, 2016 Category: Dermatology Source Type: news

Sensus Healthcare postpones IPO
Sensus Healthcare reportedly postponed its initial public offering today, after setting terms earlier this month with a midpoint raise of $20 million. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100 Vision photon X-ray low-energy superficial radiotherapy systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinomas. The company said March 9 that it planned to float more than 1.8 million shares at $10 to $12 apiece, working out to a low-end raise of $18.2 million and a high end of $21.8 million. A mere 8 IPOs have priced in 2016, all in the health...
Source: Mass Device - March 30, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Dermatology Sensus Healthcare LLC Source Type: news

Online skin cancer risk assessment tool can predict non-melanoma skin cancer
A new online tool allows people to assess their risks of developing skin cancer in the next three years. Aimed at people over 40, the tool determines the risk level in only a few questions. (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2016 Category: Consumer Health News Source Type: news

Sensus Healthcare sets terms on $20m IPO
Sensus Healthcare yesterday set the terms on an initial public offering that would raise $20 million at the mid-point. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100 Vision photon X-ray low-energy superficial radiotherapy systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinoma. Sensus said it plans to float more than 1.8 million shares at $10 to $12 apiece, working out to a low-end raise of $18.2 million and a high end of $21.8 million. Sensus said it’s won 510(k) clearance from the FDA, CE Mark approval in the European Union and nods from the China Food...
Source: Mass Device - March 10, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Radiosurgery Sensus Healthcare LLC Source Type: news

New NICE guidelines on sun exposure warn 'tanning is unsafe'
"No safe way to suntan, new NICE guidance warns," BBC News reports. The guidelines, produced by the National Institute for Health and Care Excellence (NICE), also stresses the benefits of moderate sun exposure. This will help prevent vitamin D deficiency; which is more common in the UK than many people realise. It is estimated that around one in five adults and older children (aged between 11 and 18) have low vitamin D status. The figure is around one in seven for younger children.   What are the risks of overexposure? Sunlight contains ultraviolet A (UVA) and ultraviolet B (UVB) radiation, both of whi...
Source: NHS News Feed - February 10, 2016 Category: Consumer Health News Tags: Lifestyle/exercise Cancer QA articles Source Type: news

Average person with atopic dermatitis has no increased risk of actinic keratosis or nonmelanoma skin cancer
People with atopic dermatitis do not appear to be at greater risk for actinic keratosis or basal cell and squamous cell cancer, according to a recent population-based, cross-sectional study. “This is the first study to examine the association between atopic dermatitis and actinic keratosis [AK].... (Source: Skin and Allergy News)
Source: Skin and Allergy News - February 8, 2016 Category: Dermatology Source Type: news

Vitamin Prevents Skin Cancer: Only in Australia?Vitamin Prevents Skin Cancer: Only in Australia?
A phase 3 trial indicates that daily vitamin B3 prevents nonmelanoma skin cancer in high-risk patients. But experts wonder if it applies to other lands with different people. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Carcinoma: Basal Cell and Squamous Cell Carcinoma
Learn about the signs and symptoms of two forms of non-melanoma skin cancer and how they are diagnosed and treated. Also find out the best ways to prevent carcinoma. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 22, 2015 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions (Source: WebMD Health)
Source: WebMD Health - October 22, 2015 Category: Consumer Health News Source Type: news

B Vitamin May Help Ward Off Some Skin Cancers
Study found high-risk patients who took nicotinamide daily developed fewer non-melanoma lesions (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - October 22, 2015 Category: Cancer & Oncology Source Type: news

Vitamin B3 Tied to Lower Risk for Nonmelanoma Skin Cancer (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM Nicotinamide, a form of vitamin B3, is associated with reduced risk for developing nonmelanoma skin cancer among … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 22, 2015 Category: Primary Care Source Type: news